80 related articles for article (PubMed ID: 9510197)
1. Antiviral activities of individual murine IFN-alpha subtypes in vivo: intramuscular injection of IFN expression constructs reduces cytomegalovirus replication.
Yeow WS; Lawson CM; Beilharz MW
J Immunol; 1998 Mar; 160(6):2932-9. PubMed ID: 9510197
[TBL] [Abstract][Full Text] [Related]
2. In vivo expression of an interferon-alpha gene by intramuscular injection of naked DNA.
Lawson CM; Yeow WS; Lee CM; Beilharz MW
J Interferon Cytokine Res; 1997 May; 17(5):255-61. PubMed ID: 9181463
[TBL] [Abstract][Full Text] [Related]
3. Coimmunisation with type I IFN genes enhances protective immunity against cytomegalovirus and myocarditis in gB DNA-vaccinated mice.
Cull VS; Broomfield S; Bartlett EJ; Brekalo NL; James CM
Gene Ther; 2002 Oct; 9(20):1369-78. PubMed ID: 12365002
[TBL] [Abstract][Full Text] [Related]
4. The IFN regulatory factor 7-dependent type I IFN response is not essential for early resistance against murine cytomegalovirus infection.
Steinberg C; Eisenächer K; Gross O; Reindl W; Schmitz F; Ruland J; Krug A
Eur J Immunol; 2009 Apr; 39(4):1007-18. PubMed ID: 19283778
[TBL] [Abstract][Full Text] [Related]
5. Synergy of type I interferon-A6 and interferon-B naked DNA immunotherapy for cytomegalovirus infection.
Bartlett EJ; Cull VS; Brekalo NL; Lenzo JC; James CM
Immunol Cell Biol; 2002 Oct; 80(5):425-35. PubMed ID: 12225378
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection.
Noisakran SJ; Carr DJ
Curr Eye Res; 2000 May; 20(5):405-12. PubMed ID: 10855035
[TBL] [Abstract][Full Text] [Related]
7. Ectopic expression of DNA encoding IFN-alpha 1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis.
Noisakran S; Campbell IL; Carr DJ
J Immunol; 1999 Apr; 162(7):4184-90. PubMed ID: 10201945
[TBL] [Abstract][Full Text] [Related]
8. Anti-retroviral effects of type I IFN subtypes in vivo.
Gerlach N; Gibbert K; Alter C; Nair S; Zelinskyy G; James CM; Dittmer U
Eur J Immunol; 2009 Jan; 39(1):136-46. PubMed ID: 19130550
[TBL] [Abstract][Full Text] [Related]
9. Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein.
James CM; Abdad MY; Mansfield JP; Jacobsen HK; Vind AR; Stumbles PA; Bartlett EJ
Vaccine; 2007 Feb; 25(10):1856-67. PubMed ID: 17240000
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of recombinant adenoviral vectors expressing murine IFN-alpha in mice injected with metastatic IFN-resistant tumor cells.
Santodonato L; Ferrantini M; Palombo F; Aurisicchio L; Delmastro P; La Monica N; Di Marco S; Ciliberto G; Du MX; Taylor MW; Belardelli F
Cancer Gene Ther; 2001 Jan; 8(1):63-72. PubMed ID: 11219495
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.
Jiang W; Ren L; Jin N
J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910
[TBL] [Abstract][Full Text] [Related]
12. The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections.
Tay CH; Yu LY; Kumar V; Mason L; Ortaldo JR; Welsh RM
J Immunol; 1999 Jan; 162(2):718-26. PubMed ID: 9916691
[TBL] [Abstract][Full Text] [Related]
13. Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication.
Huarte E; Larrea E; Hernández-Alcoceba R; Alfaro C; Murillo O; Arina A; Tirapu I; Azpilicueta A; Hervás-Stubbs S; Bortolanza S; Pérez-Gracia JL; Civeira MP; Prieto J; Riezu-Boj JI; Melero I
Mol Ther; 2006 Jul; 14(1):129-38. PubMed ID: 16627004
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication.
Härle P; Cull V; Agbaga MP; Silverman R; Williams BR; James C; Carr DJ
J Virol; 2002 Jul; 76(13):6558-67. PubMed ID: 12050368
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the murine alpha interferon gene family.
van Pesch V; Lanaya H; Renauld JC; Michiels T
J Virol; 2004 Aug; 78(15):8219-28. PubMed ID: 15254193
[TBL] [Abstract][Full Text] [Related]
16. ICAM-1 is required for resistance to herpes simplex virus type 1 but not interferon-alpha1 transgene efficacy.
Noisakran S; Härle P; Carr DJ
Virology; 2001 Apr; 283(1):69-77. PubMed ID: 11312663
[TBL] [Abstract][Full Text] [Related]
17. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
Liu WJ; Wang XJ; Clark DC; Lobigs M; Hall RA; Khromykh AA
J Virol; 2006 Mar; 80(5):2396-404. PubMed ID: 16474146
[TBL] [Abstract][Full Text] [Related]
18. Type I interferons potently suppress gene expression following gene delivery using liposome(-)DNA complexes.
Sellins K; Fradkin L; Liggitt D; Dow S
Mol Ther; 2005 Sep; 12(3):451-9. PubMed ID: 15950543
[TBL] [Abstract][Full Text] [Related]
19. Interferon subtype gene therapy for regulating cytomegalovirus disease.
James CM; Bartlett EJ; Mansfield JP; Cull VS
Methods Mol Med; 2005; 116():207-19. PubMed ID: 16000864
[TBL] [Abstract][Full Text] [Related]
20. IFN-alpha gene therapy for woodchuck hepatitis with adeno-associated virus: differences in duration of gene expression and antiviral activity using intraportal or intramuscular routes.
Berraondo P; Ochoa L; Crettaz J; Rotellar F; Vales A; Martínez-Ansó E; Zaratiegui M; Ruiz J; González-Aseguinolaza G; Prieto J
Mol Ther; 2005 Jul; 12(1):68-76. PubMed ID: 15963922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
